Cargando…
Response to Zoledronic Acid Infusion in Children With Fibrous Dysplasia
Objective: This retrospective study evaluated the outcome and safety of long-term treatment with zoledronic acid, in both polyostotic and mono-ostotic fibrous dysplasia (FD) of children. Methods: The case records of children and adolescents with symptomatic FD who received zoledronic acid (0.1 mg/kg...
Autores principales: | Tripathy, Sujit Kumar, Swaroop, Shakti, Velagada, Sandeep, Priyadarshini, Debashree, Das, Rashmi Ranjan, Satpathy, Amit Kumar, Agrawal, Kanhaiyalal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732464/ https://www.ncbi.nlm.nih.gov/pubmed/33330278 http://dx.doi.org/10.3389/fped.2020.582316 |
Ejemplares similares
-
Osteoid Osteoma of Distal Fibula: A Rare Location and its Management
por: Nanda, Saurav Narayan, et al.
Publicado: (2019) -
Intralesional zoledronate: A novel therapy to treat fibrous dysplasia
por: Gopinathan, Nirmal Raj, et al.
Publicado: (2020) -
Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia
por: Di Pede, Chiara, et al.
Publicado: (2016) -
Eastern India Collaboration on Multisystem Inflammatory Syndrome in Children (EICOMISC): A Multicenter Observational Study of 134 Cases
por: Nayak, Snehamayee, et al.
Publicado: (2022) -
Co-administration of Systemic and Intralesional Zoledronic Acid in a Case of Fibrous Dysplasia: A Potentially Novel Therapy
por: Bhadada, Sanjay Kumar, et al.
Publicado: (2019)